Overview

Examining The Efficacy, Safety And Improved Tolerability Of Travoprost BAK Free Ophthalmic Solution (Travatan-Z) Compared To Prior Prostaglandin Therapy

Status:
Completed

Trial end date:
2007-08-01

Target enrollment:

Participant gender:

Summary

Examine the safety, tolerability and efficacy of travoprost benzalkonium chloride (BAK) free ophthalmic solution compared to either latanoprost or bimatoprost monotherapy.

Phase:

Phase 4

Details

Lead Sponsor:

Alcon Research

Treatments:

Ophthalmic Solutions
Travoprost